Immuno-oncology agents for cancer therapySubscription
Abstract: Until recently, cancer therapy comprised of four main types of treatment: surgery, radiotherapy, chemotherapy and targeted therapy. Over the past decade, immuno-oncology (IO) has emerged as a novel and important approach to cancer treatment through the stimulation of the body’s own immune system to kill cancer cells. This newly recognised method of treating cancer is rapidly developing, with many accelerated approvals by the US Food and Drug Administration and European Medicines ...
Special report: COVID-19 pandemic
Pharmacists will be on the front line as the coronavirus crisis unfolds. Here's the latest advice and developments as they happen from The Pharmaceutical Journal team.
Boots sees profits almost halve in 2019
First COVID-19 treatment to be made available for use in UK outside a clinical trial
Pharmacy teams to support care homes with 'clinical review' of patients amid COVID-19 response
All provisionally registered trainees must be risk-assessed before starting work, regulator says
- pause slideshow
